Treatment of Severe Hyperkalemia (K+ 6.5 mEq/L)
A potassium of 6.5 mEq/L is a medical emergency requiring immediate hospital admission and urgent treatment to prevent life-threatening cardiac arrhythmias, regardless of symptoms. 1, 2, 3
Immediate Assessment (Within Minutes)
- Obtain an ECG immediately to assess for cardiac manifestations including peaked T waves, flattened P waves, prolonged PR interval, or widened QRS complex 1, 2
- Rule out pseudohyperkalemia by verifying proper blood sampling technique (no fist clenching, no hemolysis, prompt processing) 1, 4
- Any ECG changes mandate emergency treatment regardless of the exact potassium level 1, 2
Emergency Treatment Algorithm
Step 1: Cardiac Membrane Stabilization (Start Immediately if ECG Changes Present)
Administer intravenous calcium first to protect against arrhythmias within 1-3 minutes: 5, 1, 4
- Calcium gluconate 10%: 15-30 mL IV over 2-5 minutes (preferred for peripheral access) 1, 4
- Alternative: Calcium chloride 10%: 5-10 mL IV over 2-5 minutes (central line preferred) 1, 4
- Critical caveat: Calcium does NOT lower potassium—it only stabilizes the cardiac membrane temporarily (30-60 minutes) 5, 1, 4
- May repeat dose if no ECG improvement within 5-10 minutes 4
- Continuous cardiac monitoring is mandatory during and after administration 4
Step 2: Shift Potassium Intracellularly (Administer Simultaneously)
Give all three agents together for maximum effect: 5, 1, 4
Insulin 10 units regular IV + 25g dextrose (50 mL of D50W) - onset 15-30 minutes, lasts 4-6 hours 5, 1, 4
Nebulized albuterol 10-20 mg in 4 mL - onset 30 minutes, lasts 2-4 hours 5, 1, 4
Sodium bicarbonate 50 mEq IV over 5 minutes ONLY if metabolic acidosis present (pH <7.35, bicarbonate <22 mEq/L) 5, 1, 4
Step 3: Remove Potassium from Body (Initiate Within 1 Hour)
Choose based on renal function and clinical context: 5, 1, 4
Loop diuretics (furosemide 40-80 mg IV) if adequate kidney function (eGFR >30 mL/min) and patient is not oliguric 5, 1, 4
Hemodialysis is the most effective and reliable method for severe hyperkalemia, especially if: 5, 1, 4, 3
Newer potassium binders (preferred over sodium polystyrene sulfonate): 1, 4, 6
Medication Management During Acute Episode
At K+ 6.5 mEq/L, temporarily discontinue or reduce RAAS inhibitors (ACE inhibitors, ARBs, mineralocorticoid antagonists) 1, 2, 4
- Also review and hold: NSAIDs, potassium-sparing diuretics, trimethoprim, heparin, beta-blockers, potassium supplements, salt substitutes 5, 4
Monitoring Protocol
- Recheck potassium every 2-4 hours after initial treatment until stable below 5.5 mEq/L 4
- Continuous cardiac monitoring until potassium <6.0 mEq/L 1, 2
- Monitor glucose hourly for 4-6 hours after insulin administration 4
After Acute Resolution: Preventing Recurrence
Once potassium <5.5 mEq/L, initiate potassium binder and restart RAAS inhibitors at lower dose (if indicated for heart failure or proteinuric kidney disease): 5, 1, 4
- Start SZC 5-10g daily or patiromer 8.4g daily 4, 6
- Do NOT permanently discontinue RAAS inhibitors—they provide mortality benefit in cardiovascular and renal disease 1, 2, 4
- Recheck potassium within 1 week of restarting RAAS inhibitors 5, 4
Critical Pitfalls to Avoid
- Never delay treatment while waiting for repeat lab confirmation if ECG changes are present 1, 2
- Never use sodium bicarbonate without metabolic acidosis—it is ineffective and wastes time 5, 4
- Never give insulin without glucose—hypoglycemia can be life-threatening 5, 4
- Remember that calcium, insulin, and beta-agonists are temporizing measures only—they do NOT remove potassium from the body 5, 4
- Do not rely solely on ECG findings—they are variable and less sensitive than lab values 4
- Avoid sodium polystyrene sulfonate (Kayexalate)—it has delayed onset and risk of bowel necrosis 4, 6